Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.

Chu CS, Bancone G, Soe NL, Carrara VI, Gornsawun G, Nosten F.

Version 2. Wellcome Open Res. 2019 Apr 9 [revised 2019 Jan 1];4:25. doi: 10.12688/wellcomeopenres.15100.2. eCollection 2019.

2.

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, Thinraow S, Wilairisak P, Raksapraidee R, Carrara VI, Paw MK, Wiladphaingern J, Proux S, Bancone G, Sriprawat K, Lee SJ, Jeeyapant A, Watson J, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2019 Apr 8;68(8):1311-1319. doi: 10.1093/cid/ciy735.

3.

Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.

Bancone G, Menard D, Khim N, Kim S, Canier L, Nguong C, Phommasone K, Mayxay M, Dittrich S, Vongsouvath M, Fievet N, Le Hesran JY, Briand V, Keomany S, Newton PN, Gorsawun G, Tardy K, Chu CS, Rattanapalroj O, Dong LT, Quang HH, Tam-Uyen N, Thuy-Nhien N, Hien TT, Kalnoky M, Nosten F.

Malar J. 2019 Jan 23;18(1):20. doi: 10.1186/s12936-019-2652-y.

4.

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Llanos-Cuentas A, Lacerda MVG, Hien TT, Vélez ID, Namaik-Larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, Costa MRF, Chuquiyauri R, Casapía M, Nguyen CH, Aruachan S, Papwijitsil R, Nosten FH, Bancone G, Angus B, Duparc S, Craig G, Rousell VM, Jones SW, Hardaker E, Clover DD, Kendall L, Mohamed K, Koh GCKW, Wilches VM, Breton JJ, Green JA.

N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.

5.

Laboratory validation and field usability assessment of a point-of-care test for serum bilirubin levels in neonates in a tropical setting.

Thielemans L, Hashmi A, Priscilla DD, Kho Paw M, Pimolsorntong T, Ngerseng T, Van Overmeire B, Proux S, Nosten F, McGready R, Carrara VI, Bancone G.

Version 2. Wellcome Open Res. 2018 Nov 23 [revised 2018 Jan 1];3:110. doi: 10.12688/wellcomeopenres.14767.2. eCollection 2018.

6.

Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.

Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, Penpitchaporn P, Chu CS, Nosten F, Domingo GJ.

Am J Trop Med Hyg. 2019 Jan;100(1):213-221. doi: 10.4269/ajtmh.18-0612.

7.

Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.

Ndila CM, Uyoga S, Macharia AW, Nyutu G, Peshu N, Ojal J, Shebe M, Awuondo KO, Mturi N, Tsofa B, Sepúlveda N, Clark TG, Band G, Clarke G, Rowlands K, Hubbart C, Jeffreys A, Kariuki S, Marsh K, Mackinnon M, Maitland K, Kwiatkowski DP, Rockett KA, Williams TN; MalariaGEN Consortium.

Lancet Haematol. 2018 Aug;5(8):e333-e345. doi: 10.1016/S2352-3026(18)30107-8. Epub 2018 Jul 20.

8.

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, Raksapraidee R, Carrara VI, Bancone G, Watson J, Moore KA, Wiladphaingern J, Proux S, Sriprawat K, Winterberg M, Cheah PY, Chue AL, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2018 Oct 30;67(10):1543-1549. doi: 10.1093/cid/ciy319.

9.

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.

Bancone G, Gornsawun G, Chu CS, Porn P, Pal S, Bansil P, Domingo GJ, Nosten F.

PLoS One. 2018 May 8;13(5):e0196716. doi: 10.1371/journal.pone.0196716. eCollection 2018.

10.

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.

Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ.

PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006440. doi: 10.1371/journal.pntd.0006440. eCollection 2018 Apr.

11.

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.

Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, Chu CS, Bancone G, Carrara VI, Singhasivanon P, White NJ, Nosten F, McGready R.

Clin Infect Dis. 2018 Sep 14;67(7):1000-1007. doi: 10.1093/cid/ciy235.

12.

Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.

Thielemans L, Gornsawun G, Hanboonkunupakarn B, Paw MK, Porn P, Moo PK, Van Overmeire B, Proux S, Nosten F, McGready R, Carrara VI, Bancone G.

Wellcome Open Res. 2018 Jan 2;3:1. doi: 10.12688/wellcomeopenres.13373.1. eCollection 2018.

13.

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.

Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L.

Malar J. 2018 Mar 2;17(1):101. doi: 10.1186/s12936-018-2248-y. Review.

14.

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.

Kalnoky M, Bancone G, Kahn M, Chu CS, Chowwiwat N, Wilaisrisak P, Pal S, LaRue N, Leader B, Nosten F, Domingo GJ.

Eur J Haematol. 2018 Mar;100(3):294-303. doi: 10.1111/ejh.13013. Epub 2018 Jan 15.

15.

Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border.

Bancone G, Gilder ME, Chowwiwat N, Gornsawun G, Win E, Cho WW, Moo E, Min AM, Charunwatthana P, Carrara VI, White NJ, Nosten F, McGready R.

Wellcome Open Res. 2017 Nov 2;2:72. doi: 10.12688/wellcomeopenres.12338.2. eCollection 2017.

16.

Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.

Awab GR, Imwong M, Bancone G, Jeeyapant A, Day NPJ, White NJ, Woodrow CJ.

Am J Trop Med Hyg. 2017 Dec;97(6):1782-1787. doi: 10.4269/ajtmh.17-0290. Epub 2017 Oct 26.

17.

Methods for the field evaluation of quantitative G6PD diagnostics: a review.

Ley B, Bancone G, von Seidlein L, Thriemer K, Richards JS, Domingo GJ, Price RN.

Malar J. 2017 Sep 11;16(1):361. doi: 10.1186/s12936-017-2017-3. Review.

18.

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.

Bancone G, Kalnoky M, Chu CS, Chowwiwat N, Kahn M, Malleret B, Wilaisrisak P, Rénia L, Domingo GJ, Nosten F.

Sci Rep. 2017 Aug 29;7(1):9822. doi: 10.1038/s41598-017-10045-2.

19.

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.

Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Möhrle JJ, Rousell V, Mohamed K, Qureshi A, Narayan S, Yubon N, Miller A, Nosten FH, Luzzatto L, Duparc S, Kleim JP, Green JA.

Am J Trop Med Hyg. 2017 Sep;97(3):702-711. doi: 10.4269/ajtmh.16-0779. Epub 2017 Jul 27.

20.

Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.

Bancone G, Malleret B, Suwanarusk R, Chowwiwat N, Chu CS, McGready R, Rénia L, Nosten F, Russell B.

J Infect Dis. 2017 Jul 15;216(2):263-266. doi: 10.1093/infdis/jix278.

Supplemental Content

Loading ...
Support Center